1. Home
  2. CRVS vs TIGR Comparison

CRVS vs TIGR Comparison

Compare CRVS & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo UP Fintech Holding Ltd representing fifteen

TIGR

UP Fintech Holding Ltd representing fifteen

HOLD

Current Price

$6.36

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
TIGR
Founded
2014
2014
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
CRVS
TIGR
Price
$14.50
$6.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$28.20
$14.20
AVG Volume (30 Days)
1.1M
2.5M
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
48.04
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.74
Revenue Next Year
N/A
$13.91
P/E Ratio
N/A
$9.77
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$5.95
52 Week High
$26.95
$13.55

Technical Indicators

Market Signals
Indicator
CRVS
TIGR
Relative Strength Index (RSI) 45.22 35.87
Support Level $12.95 N/A
Resistance Level $18.73 $8.77
Average True Range (ATR) 0.94 0.28
MACD 0.07 -0.01
Stochastic Oscillator 51.17 26.21

Price Performance

Historical Comparison
CRVS
TIGR

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

Share on Social Networks: